Targeting of cancer-related proteins with PNA oligomers.

Margus Pooga , Ulo Langel
Current Cancer Drug Targets 1 ( 3) 231 -239

19
2001
Role of autophagy in PepFect14 transfection

Margus Pooga , Ülo Langel , Helerin Margus , Moataz Dowaidar

1
2017
The role of integrin β1 in the heterogeneity of human embryonic stem cells culture.

Ade Kallas-Kivi , Annika Trei , Artjom Stepanjuk , Katrin Ruisu
Biology Open 7 ( 11)

5
2018
Insights into cell entry and intracellular trafficking of peptide and protein drugs provided by electron microscopy.

Helerin Margus , Kärt Padari , Margus Pooga
Advanced Drug Delivery Reviews 65 ( 8) 1031 -1038

18
2013
Adenosine–oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton

Helin Räägel , Marje Lust , Asko Uri , Margus Pooga
FEBS Journal 275 ( 14) 3608 -3624

16
2008
Lack of Gata3 results in conotruncal heart anomalies in mouse

Raivo Raid , Dagni Krinka , Lairi Bakhoff , Eltyeb Abdelwahid
Mechanisms of Development 126 ( 1-2) 80 -89

26
2009
Distribution of CPP-Protein Complexes in Freshly Resected Human Tissue Material

Ülo Langel , Margus Pooga , Külliki Saar , Helgi Saar
Pharmaceuticals 3 ( 3) 621 -635

1
2010
Liquid-phase synthesis of a pegylated adenosine-oligoarginine conjugate, cell-permeable inhibitor of cAMP-dependent protein kinase.

Kaido Viht , Kärt Padari , Gerda Raidaru , Juhan Subbi
Bioorganic & Medicinal Chemistry Letters 13 ( 18) 3035 -3039

21
2003
A study of the interaction of some neuropeptides and their analogs with bilayer lipid membranes and liposomes

Tibor Hianik , Udo Kaatze , David F. Sargent , Roland Krivánek
Bioelectrochemistry and Bioenergetics 42 ( 2) 123 -132

13
1997
von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice

Ade Kallas , Sulev Kuuse , Toivo Maimets , Margus Pooga
Thrombosis Research 120 ( 6) 911 -919

11
2007
NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation.

Gemma Carreras-Badosa , Julia Maslovskaja , Kapilraj Periyasamy , Egon Urgard
Biomaterials 262 120316 -120316

26
2020
Formulation of Stable and Homogeneous Cell-Penetrating Peptide NF55 Nanoparticles for Efficient Gene Delivery In Vivo.

Krista Freimann , Piret Arukuusk , Kaido Kurrikoff , Ly Pärnaste
Molecular therapy. Nucleic acids 10 28 -35

21
2018
Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction.

Helin Räägel , Margot Hein , Asko Kriiska , Pille Säälik
Cellular and Molecular Life Sciences 70 ( 24) 4825 -4839

24
2013
S4(13)-PV Cell-Penetrating Peptide Forms Nanoparticle-Like Structures to Gain Entry Into Cells

Kärt Padari , Kaida Koppel , Annely Lorents , Mattias Hällbrink
Bioconjugate Chemistry 21 ( 4) 774 -783

33
2010
Differential Endosomal Pathways for Radically Modified Peptide Vectors

Piret Arukuusk , Ly Pärnaste , Helerin Margus , N. K. Jonas Eriksson
Bioconjugate Chemistry 24 ( 10) 1721 -1732

43
2013
Protein Delivery with Transportans Is Mediated by Caveolae Rather Than Flotillin-Dependent Pathways

Pille Säälik , Kärt Padari , Aira Niinep , Annely Lorents
Bioconjugate Chemistry 20 ( 5) 877 -887

41
2009
Characterization of Peptide-Oligonucleotide Complexes Using Electron Microscopy, Dynamic Light Scattering, and Protease Resistance Assay.

Kärt Padari , Ly Porosk , Piret Arukuusk , Margus Pooga
Methods of Molecular Biology 2036 127 -139

3
2019
Protein cargo delivery properties of cell-penetrating peptides. A comparative study.

Pille Säälik , Anna Elmquist , Mats Hansen , Kärt Padari
Bioconjugate Chemistry 15 ( 6) 1246 -1253

172
2004
Cell transduction pathways of transportans.

Kärt Padari , Pille Säälik , Mats Hansen , Kaida Koppel
Bioconjugate Chemistry 16 ( 6) 1399 -1410

77
2005